Trial of ERapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance

NCT04230499 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Familial Adenomatous Polyposis

Interventions

DRUG: Encapsulated Rapamycin (eRapa)

Sponsor

Rapamycin Holdings Inc.

Collaborators

[object Object]
[object Object]